Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nguyet M Hoang"'
Autor:
Oorvashi Roy Puli, Brian P Danysh, Elena McBeath, Deepankar K Sinha, Nguyet M Hoang, Reid T Powell, Heather E Danysh, Maria E Cabanillas, Gilbert J Cote, Marie-Claude Hofmann
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 20, Iss 11, Pp 1121-1134 (2018)
The ETS family of transcription factors is involved in several normal remodeling events and pathological processes including tumor progression. ETS transcription factors are divided into subfamilies based on the sequence and location of the ETS domai
Externí odkaz:
https://doaj.org/article/6927093673ab4f368f417b8cb1f11da6
Autor:
Lixin Rui, Christian M. Capitini, Thomas A. Waldmann, Madelyn Chen, Samantha Bebel, Apoorv Kondapelli, Alexander Rosiejka, Yangguang Li, Yunxia Liu, Amanda Kelm, David T. Yang, Shanxiang Zhang, Anusara Daenthanasanmak, Paul D. Bates, Fen Zhu, Nguyet M. Hoang, Li Lu, Shuichi Kimpara
Supplementary Methods, Supplementary Figures and Figure Legends. Figure S1. EGR1 is a downstream target of BCR and JAK1 signaling (related to Figure 1). Figure S2. Sensitivity of MCL cell lines to EGR1 shRNAs and statistical analysis (related to Figu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f3090fbe8e8e01eb05a340f7ecd43dd
https://doi.org/10.1158/1541-7786.22527053
https://doi.org/10.1158/1541-7786.22527053
Autor:
Lixin Rui, Christian M. Capitini, Thomas A. Waldmann, Madelyn Chen, Samantha Bebel, Apoorv Kondapelli, Alexander Rosiejka, Yangguang Li, Yunxia Liu, Amanda Kelm, David T. Yang, Shanxiang Zhang, Anusara Daenthanasanmak, Paul D. Bates, Fen Zhu, Nguyet M. Hoang, Li Lu, Shuichi Kimpara
Early growth response gene (EGR1) is a transcription factor known to be a downstream effector of B-cell receptor signaling and Janus kinase 1 (JAK1) signaling in diffuse large B-cell lymphoma (DLBCL). While EGR1 is characterized as a tumor suppressor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e7fc4f731aa0924678a485fd314a9541
https://doi.org/10.1158/1541-7786.c.6545306.v1
https://doi.org/10.1158/1541-7786.c.6545306.v1
Autor:
Lixin Rui, Christian M. Capitini, Thomas A. Waldmann, Madelyn Chen, Samantha Bebel, Apoorv Kondapelli, Alexander Rosiejka, Yangguang Li, Yunxia Liu, Amanda Kelm, David T. Yang, Shanxiang Zhang, Anusara Daenthanasanmak, Paul D. Bates, Fen Zhu, Nguyet M. Hoang, Li Lu, Shuichi Kimpara
Supplementary Table S1 including analyzed RNA-seq and ChIP-seq data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e067120d4d6228b04ec19938a9eaf06
https://doi.org/10.1158/1541-7786.22527050
https://doi.org/10.1158/1541-7786.22527050
Autor:
Amanda Kelm, Samantha Bebel, Shanxiang Zhang, Paul D. Bates, Shuichi Kimpara, Alexander Rosiejka, Nguyet M. Hoang, Apoorv Kondapelli, Anusara Daenthanasanmak, Thomas A. Waldmann, Christian M. Capitini, David T. Yang, Yunxia Liu, Madelyn Chen, Lixin Rui, Yangguang Li, Fen Zhu, Li Lu
Publikováno v:
Mol Cancer Res
Early growth response gene (EGR1) is a transcription factor known to be a downstream effector of B-cell receptor signaling and Janus kinase 1 (JAK1) signaling in diffuse large B-cell lymphoma (DLBCL). While EGR1 is characterized as a tumor suppressor
Autor:
Paul D. Bates, Nguyet M. Hoang, Christian M. Capitini, Krystle Nomie, Ian Rumball, Hui Guo, Michael Wang, Hui Zhang, Liang Zhang, Kaitlyn R. Seibold, Lixin Rui, Yangguang Li, Wei Xu, Hunter Cameron, David T. Yang, Shanxiang Zhang, Fen Zhu, Li Lu, Fangyu Wang
Publikováno v:
Leukemia
PRMT5, which regulates gene expression by symmetric dimethylation of histones and non-histone target proteins, is overexpressed and plays a pathogenic role in many cancers. In diffuse large B cell lymphoma (DLBCL), the mechanisms of PRMT5 dysregulati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3796c2dcc72f099d19031186aabca882
https://europepmc.org/articles/PMC7494157/
https://europepmc.org/articles/PMC7494157/
Inhibition of the STAT3 target SGK1 sensitizes diffuse large B cell lymphoma cells to AKT inhibitors
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 9, Iss 4, Pp 1-6 (2019)
Blood Cancer Journal, Vol 9, Iss 4, Pp 1-6 (2019)